The global medical rubber stopper market size is anticipated to reach USD 2.57 billion by 2030, registering a CAGR of 5.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global market is witnessing significant growth due to the expansion of the healthcare, pharmaceutical, and biotechnology industries. The heightened focus on drug safety and efficacy is leading to more stringent regulations and standards for pharmaceutical packaging, consequently driving the demand for medical rubber stoppers that ensure the integrity and sterility of drugs. In addition, governments and public health organizations around the world initiated mass vaccination campaigns to immunize large segments of their populations.
These campaigns required a vast quantity of vaccine vials and stoppers to store and administer the vaccines. Hence, mass vaccination campaigns triggered market growth. Preventive medicine in animal health focuses on proactively protecting animals from diseases rather than treating them after they become sick. Vaccination is one of the most effective tools in preventing the spread of infectious diseases among animals. It involves the development and adherence to routine vaccination schedules for different species of animals. Hence, the increasing demand for vaccines in veterinary medicine escalates the demand for medical rubber stoppers for vaccine vials and prefilled syringes.
Furthermore, the high demand for prefilled syringes in the healthcare industry is a compelling driver of market growth. Prefilled syringes have gained popularity for drug delivery due to their convenience, accuracy, and reduced risk of dosing errors. However, to maintain the integrity and sterility of the medications within these syringes, high-quality medical rubber stoppers are essential. These stoppers serve as a barrier against contamination, prevent leakage, and ensure the precise delivery of medication. Moreover, the trend toward self-administration of injectable medications by patients has heightened the importance of user-friendly prefilled syringes, making specialized rubber stoppers a critical component in enhancing ease of use and overall patient compliance. Therefore, this growing demand for prefilled syringes is stimulating the product demand.
Request a free sample copy or view report summary: Medical Rubber Stopper Market Report
The Asia Pacific regional market was estimated at USD 1.92 billion in 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2033
The Teflon-coated surface treatment segment led the global market in 2022 and accounted for a revenue share of over 64.0% due to its biocompatibility, which makes it suitable for use in medical devices and rubber stoppers that encounter bodily fluids, tissues, or drugs
Moreover, Teflon-coated medical rubber stoppers possess properties, such as chemical inertness, low friction, and nonstick properties, that further drive their demand further
The human injectable application segment is anticipated to experience rapid growth over the forecast period due to the increased drug development and clinical trials, rising demand for prefilled syringes, and global vaccination drive, consequently increasing the product demand
Grand View Research has segmented the global medical rubber stoppers market on the basis of surface treatment, application, and region:
Medical Rubber Stopper Surface Treatment Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)
Siliconized
Teflon-coated
Uncoated Stoppers
Medical Rubber Stopper Application Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)
Laboratory
Diagnostic
Human Injectable
Animal Injectable
Medical Rubber Stopper Regional Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Central & South America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
List of Key Players in Medical Rubber Stopper Market
AptarGroup, Inc.
Dätwyler Holding Inc.
West Pharmaceutical Services, Inc.
Hualan NPM
Hubei Huaqiang High-Tech Co., Ltd.
Samsung Medical Rubber Co., Ltd.
Jiangsu Best New Medical Material Co, Ltd.
Bharat Rubber Works Pvt. Ltd.
Jiangyin Hongmeng Rubber Plastic Product Co., Ltd.
SHRIJI Rubber Industries
Jain Rubbers Pvt. Ltd.
Universal Medicap Ltd.
Lonstroff AG
Bormioli Pharma S.p.A.
APG Europe
Sagar Rubber Products Pvt. Ltd.
Shengzou Rubber & Plastics Co., Ltd.
"The quality of research they have done for us has been excellent..."